SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030395
Filing Date
2023-11-06
Accepted
2023-11-06 16:17:56
Documents
89
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opk20230930c_10q.htm   iXBRL 10-Q 2291724
2 EXHIBIT 31.1 ex_558970.htm EX-31.1 12388
3 EXHIBIT 31.2 ex_558971.htm EX-31.2 12310
4 EXHIBIT 32.1 ex_558972.htm EX-32.1 3895
5 EXHIBIT 32.2 ex_558973.htm EX-32.2 3800
  Complete submission text file 0001437749-23-030395.txt   11790026

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA opk-20230930.xsd EX-101.SCH 90544
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opk-20230930_cal.xml EX-101.CAL 74045
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20230930_def.xml EX-101.DEF 753130
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20230930_lab.xml EX-101.LAB 586920
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20230930_pre.xml EX-101.PRE 785375
83 EXTRACTED XBRL INSTANCE DOCUMENT opk20230930c_10q_htm.xml XML 2106134
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 231380197
SIC: 2834 Pharmaceutical Preparations